TrialAnnals of internal medicine2020

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial.

Ibrahim Aldoss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.